Home NDC 0573-0246 ANBESOL COLD SORE THERAPY
Product NDC 0573-0246
11-digit product format 005730246
Labeler code 0573
Product ID 0573-0246_7ace5d51-e912-4a2b-8f40-a861ffc778b4
Type HUMAN OTC DRUG
Nonproprietary name allantion, benzocaine, camphor, petrolatum
Dosage form OINTMENT
Route TOPICAL
Labeler GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Application part348
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2006-05-09
Marketing end 0000-00-00
Substance ALLANTOIN; BENZOCAINE; CAMPHOR (SYNTHETIC); PETROLATUM
Active strength 10 mg/g; mg/g; mg/g; mg/g
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0573-0246-25 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0573-0246-26 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0573-0246-25 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0573-0246-26 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0573-0246-25 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0573-0246-26 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0573-0246-25 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0573-0246-26 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0573-0246-25 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0573-0246-26 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0573-0246-25 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0573-0246-26 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0573-0246-25 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0573-0246-26 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0573-0246-25 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0573-0246-26 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0573-0246-25 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0573-0246-26 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0573-0246-25 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0573-0246-26 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0573-0246-25 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0573-0246-26 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0573-0246-25 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0573-0246-26 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 0573-0246-26 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 0573-0246-26 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 0573-0246-26 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0573-0246-26 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0573-0246-26 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0573-0246-26 I Inactivated by FDA bd6a592717d7…303034d00443…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0573-0246-25 ANBESOL COLD SORE THERAPY 1 in 1 BLISTER PACK OINTMENT 1 6 0573-0246-25 ANBESOL COLD SORE THERAPY 9 g in 1 TUBE OINTMENT 9 6 0573-0246-26 ANBESOL COLD SORE THERAPY 9 g in 1 TUBE OINTMENT 9 6 0573-0246-26 ANBESOL COLD SORE THERAPY 1 in 1 BLISTER PACK OINTMENT 1 6
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded allantoin ACTIVE INGREDIENT 344S277G0Z ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 benzocaine ACTIVE INGREDIENT U3RSY48JW5 ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 CAMPHOR (SYNTHETIC) ACTIVE INGREDIENT 5TJD82A1ET ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 petrolatum ACTIVE INGREDIENT 4T6H12BN9U ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 allantoin ACTIVE MOIETY 344S277G0Z ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 benzocaine ACTIVE MOIETY U3RSY48JW5 ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 CAMPHOR (SYNTHETIC) ACTIVE MOIETY 5TJD82A1ET ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 petrolatum ACTIVE MOIETY 4T6H12BN9U ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 aloe vera leaf INACTIVE INGREDIENT ZY81Z83H0X ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 alpha-tocopherol INACTIVE INGREDIENT H4N855PNZ1 ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 benzyl alcohol INACTIVE INGREDIENT LKG8494WBH ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 butylparaben INACTIVE INGREDIENT 3QPI1U3FV8 ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 glyceryl monostearate INACTIVE INGREDIENT 230OU9XXE4 ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 menthol INACTIVE INGREDIENT L7T10EIP3A ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 methylparaben INACTIVE INGREDIENT A2I8C7HI9T ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 mineral oil INACTIVE INGREDIENT T5L8T28FGP ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 propylparaben INACTIVE INGREDIENT Z8IX2SC1OH ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3 white wax INACTIVE INGREDIENT 7G1J5DA97F ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [PFIZER CONSUMER HEALTHCARE] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0573-0246 ANBESOL COLD SORE THERAPY (ALLANTION, BENZOCAINE, CAMPHOR, PETROLATUM) OINTMENT [GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC] 6 Legacy NDC, 4 package rows 20201126_25bcfa70-64f9-18d6-51b0-83282c2f84be.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0573-0246-25 00573024625 1 in 1 BLISTER PACK Historical 0573-0246-26 00573024626 1 TUBE in 1 BLISTER PACK (0573-0246-26) > 9 g in 1 TUBE 1 tube 2008-09-15 0000-00-00 No No Current